- Home
- ABUS vs FMNB Comparison
ABUS vs FMNB Comparison
Compare ABUS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- FMNB
- Stock Information
- Founded
- ABUS N/A
- FMNB 1887
- Country
- ABUS United States
- FMNB United States
- Employees
- ABUS N/A
- FMNB N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- ABUS Health Care
- FMNB Finance
- Exchange
- ABUS Nasdaq
- FMNB Nasdaq
- Market Cap
- ABUS 725.9M
- FMNB 598.6M
- IPO Year
- ABUS N/A
- FMNB N/A
- Fundamental
- Price
- ABUS $3.46
- FMNB $15.44
- Analyst Decision
- ABUS Strong Buy
- FMNB Hold
- Analyst Count
- ABUS 4
- FMNB 4
- Target Price
- ABUS $5.50
- FMNB $15.25
- AVG Volume (30 Days)
- ABUS 837.4K
- FMNB 87.9K
- Earning Date
- ABUS 11-06-2024
- FMNB 10-23-2024
- Dividend Yield
- ABUS N/A
- FMNB 4.40%
- EPS Growth
- ABUS N/A
- FMNB N/A
- EPS
- ABUS N/A
- FMNB 1.23
- Revenue
- ABUS $6,742,000.00
- FMNB $162,960,000.00
- Revenue This Year
- ABUS N/A
- FMNB N/A
- Revenue Next Year
- ABUS N/A
- FMNB $5.71
- P/E Ratio
- ABUS N/A
- FMNB $12.32
- Revenue Growth
- ABUS N/A
- FMNB N/A
- 52 Week Low
- ABUS $1.79
- FMNB $11.55
- 52 Week High
- ABUS $4.72
- FMNB $16.32
- Technical
- Relative Strength Index (RSI)
- ABUS 30.63
- FMNB 57.08
- Support Level
- ABUS $3.42
- FMNB $14.87
- Resistance Level
- ABUS $3.81
- FMNB $15.52
- Average True Range (ATR)
- ABUS 0.16
- FMNB 0.44
- MACD
- ABUS -0.04
- FMNB 0.03
- Stochastic Oscillator
- ABUS 7.41
- FMNB 73.42
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.